Fabrication pushes innovation towards success Ideas often start in small ways. With the right support, they can change the world. Across Australia and internationally, innovators are using micro‑ and nanofabrication to turn promising ideas into r...

Innovation rarely arrives fully formed. More often, it takes the right tools, expertise and persistence to move from possibility to progress. Micro‑ and nanofabrication help promising work move forward with confidence. #NCRIS #ReCreateIt #Q-Sera #Phaseslides #ONJCRI #TheGoodsideProject #SANano

We are delighted to share that A/Prof Peter Janes and A/Prof Doug Fairlie have received Pankind 2025 Research Grants, allowing them to make strides in their pancreatic cancer research.

➡️ Read more: https://ow.ly/Coqq50XsqUl

#PancreaticCancer #CancerResearch #ResearchGrants #ONJCRI

Significant new results from ONJCRI’s Phase II rare cancer clinical trial on combination immunotherapy in dMMR/MSI-H non-colorectal cancers have been published in @jamaoncology.com.

➡️ Learn more: jamanetwork.com/journals/jam...

#RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI

ONJCRI researchers have linked two nervous system components to bowel cancer growth, creating promising new avenues for treatment with existing approved migraine therapies.

The findings were published in The BMJ Oncology today.

➡️ https://ow.ly/PCFE50XfWVh

#BowelCancer #Neuropeptides #ONJCRI

Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions.

➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT

#CellDeath #Apoptosis #ONJCRI

📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia.

Read the review here: ow.ly/jlvA50Wze5Y

#LungCancerResearch #CancerResearch #Biobank #ONJCRI

We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI.

Thank you to ACRF for making this new facility become a reality.

➡️ Read more about our new Centre: ow.ly/mcJl50WtK57

#ACRF #CancerResearch #PrecisionMedicine #ONJCRI

Dr Lisa Mielke awarded ARC Future Fellowship This ARC Future Fellowship will allow Dr Mielke and her team to research new molecules for future drug and vaccine development.

Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development.

➡️ Learn more: ow.ly/GSAP50Wo6L1

#FutureFellowship #ONJCRI

Prof Andrew Scott receives two awards at SNMMI meeting Congratulations to our Prof Andrew Scott AM who received two awards at the SNMMI meeting in the US last week.

Congratulations to Professor Andrew Scott AM who received two awards at the SNMMI meeting last week.
➡️ The Minoshima-Pappas award
➡️️ The Henry Wagner Jr lecture award

Read more: ow.ly/ExHa50WkR3C
@snm-mi.bsky.social‬

#SNMMI2025 #NuclearMedicine #Theranostics #ONJCRI

Relive the highlights of the launch of our Impact Strategy 2025–2029! Thank you to everyone who attended, shared insights, and celebrated this milestone with us.

#EffectiveTolerableAccessible #ImpactStrategy #BedsideToBenchToBedside #ONJCRI

youtu.be/M3U-RnVz5Qw

Dr Lisa Mielke awarded Colorectal Cancer Alliance funding This important Colorectal Cancer Alliance grant will allow Dr Lisa Mielke to conduct further research into colorectal cancer.

🎉 Congratulations to Dr Lisa Mielke, who has been awarded a grant totalling US$310,000 by the Colorectal Cancer Alliance Project Cure CRC initiative.

Read more: ow.ly/K6Rc50VKYnp

#ColorectalCancer #CancerResearch #ONJCRI

🎗️ Rare Cancers Awareness Day 🌏

🧬 Dr Quentin Gouil utilises cutting-edge gene sequencing and bioinformatics to help our scientists obtain a rapid and comprehensive view of the inner workings of a tumour cell.

Learn more here: ow.ly/FiTK50WgvrZ

#RareCancers #Genomics #ONJCRI

💛 Cancer research breakthroughs give patients the gift of more time.

🔬This EOFY, click here and learn about how The John Brumby Impact Fund supports bold cancer research at the Olivia Newton-John Cancer Research Institute: ow.ly/HUhx50WcEna

#EOFY #Cancer #Research #ONJCRI #survivor

ONJCRI is proud to share its new Impact Strategy 2025–2029, a framework to drive innovative and patient-centred research that translates to cancer treatments sooner.

➡️ Learn more: ow.ly/2aLz50W7v2S

#EffectiveTolerableAccessible #CancerResearch #ONJCRI

📚 Congratulations to Dr Yi (David) Ju who received the Editorial Contribution Award and Author Service Award from ‪@springernature.com‬.

These awards are a recognition of Dr Ju's contributions as an Editor for the Journal of Materials Science.

#ONJCRI #ScientificJournal

📣 We are delighted to share our 2024 Annual Report: www.onjcri.org.au/ab...

💛 The stories and breakthroughs featured in the report reflect our team's dedication to creating a future where cancer treatment is more effective, tolerable and accessible for all.

#AnnualReport #ONJCRI

Congratulations to Sakshi Arora, Prof Andrew Scott AM and A/Prof Peter Janes whose review paper on ADAM metalloproteases was published in Cancers this week.

➡️ Read the article to learn more about ADAMs: ow.ly/2YHG50VW5vk

#ADAMmetalloproteases #CancerResearch #ONJCRI

🧬 Meet the talented team behind the Melbourne Advanced Gene Editing Centre (MAGEC), who generate sophisticated pre-clinical models allowing #ONJCRI to make strides in its cancer research.

➡️ ow.ly/jZtx50VLL2h
#CRISPR

MAGEC is supported by Phenomics Australia and NCRIS.

Today is World DNA Day, a celebration of the discovery of DNA and of the scientific advances that our understanding of DNA has made possible.

➡️ Read insights from Dr Conor Kearney on the link between DNA and cancer in our latest website article: ow.ly/9nSB50VBnzx

#DNADay #ONJCRI

A review about CRISPR Activation Technology by Dr Eddie La Marca, Professor Marco Herold, and colleagues from @wehi-research.bsky.social, has been published in the Annual Review of Cancer Biology.

Congratulations to the authors!

🧬 Read the review: ow.ly/9YjS50VAxlU

#CRISPR #ONJCRI

2024 Student Prize awarded to Pavitha Parathan Every year, ONJCRI awards a Student Prize to a postgraduate student making a significant contribution to their field.

Congratulations to Pavitha Parathan from the Mucosal Immunity Lab for being awarded the 2024 ONJCRI Student Prize!

Read more about Pavitha's cancer research journey: ow.ly/LGx650VsU2h

#CancerResearch #ONJCRI

🎉 We are thrilled to share that Dr Purva Trivedi has been awarded a top-up scholarship from the Jreissati Pancreatic Cancer Centre.

"I am determined to identify novel HCK-dependent targets to treat pancreatic cancer.”

#PancreaticCancer #ONJCRI
@latrobeuni.bsky.social @purvat.bsky.social

ONJCRI teams up with HPE to revolutionize cancer research!

It aims to accelerate discoveries and improve patient outcomes.

Read More: https://tinyurl.com/5aduptk7

#CancerResearch #ONJCRI #HPE #HealthcareAdvancement #ittechpulse #bestplacetowork

🔬 We are delighted to share that our talented researchers Dr Jessica Da Gama Duarte and Dr Tirta (Mario) Djajawi have been awarded generous grants by the CASS Foundation.

⭐️ Congratulations to both!

#MedicalGrants #MedicalResearch #ONJCRI #CancerResearch